Clinical Trial Update: Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating carboplatin, paclitaxel, and bevacizumab with or without everolimus in metastatic malignant melanoma has completed. Results were post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• CARBOPLATIN (Carboplatin)
• Everolimus (everolimus)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Melanoma (Skin) | Phase 2 | Status: COMPLETED | Results posted: 2017-03-07